What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study

• Váldodahkkit: Marion Fiorentino (Dahkki), Christel Protière (Dahkki), Luis Sagaon-Teyssier (Dahkki), Mohamed Mimi (Dahkki), Lisa Fressard (Dahkki), MichaelP Arnold (Dahkki), Olivier Lambotte (Dahkki), Janine Barbot (Dahkki), Sylvie Fainzang (Dahkki), Laurence Meyer (Dahkki), Cécile Goujard (Dahkki), Marie Préau (Dahkki), Bruno Spire (Dahkki), Marie Suzan-Monti (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2019-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Objectives: Enrolling people living with HIV with undetectable viral load into HIV cure-related clinical trials (HCRCT) is challenging. Few data are currently available about the individual factors that influence willingness to participate in HCRCT (WPHCRCT). We hypothesised that WPHCRCT would be mo...